跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xilpod-200 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xilpod-200
Approved
STANDARD
Xilpod-200
Sance Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
53d992d894e87a32
Company
Sance Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
53d992d894e87a32
Drug Approval Philippines Name
Xilpod-200
Product Name
Xilpod-200
Registration Number
DRP-13322
Brand Name
Xilpod-200
Generic Name
Cefpodoxime ( As Proxetil)
Dosage Form
Film-Coated Tablet
Dosage Strength
200 mg
Manufacturer
Sance Laboratories Pvt. Ltd.
Importer
Pharmakon Biotec Inc.
Distributor
Pharmakon Biotec Inc.
Issuance Date
26 January 2023
Expiry Date
26 January 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
53d992d894e87a32
Type
Standard
Back to Philippines FDA Approvals